Search

Filters

Clear Filters
3:00 PM - 4:00 PM ET

2033 - Ten-Year Outcomes of the Phase III ESO-Shanghai 1 Trial: Comparing Paclitaxel Plus Fluorouracil Group vs. Cisplatin Plus Fluorouracil Group in Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Speaker: Chen, Yun, MD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
3:00 PM - 4:00 PM ET

2034 - Personalized Circulating Tumor DNA Predicts Risk of Recurrence after Tri-Modality Therapy in Esophageal Squamous Cell Carcinoma Patients Achieving Pathologic Complete Response
Speaker: Cheng, Jason Chia-Hsien, MD, PhD, MS, FASTRO - National Taiwan University Hospital, Taipei, Taipei
3:00 PM - 4:00 PM ET

2035 - Differences In Sociodemographic and Treatment Patterns By Medicaid Enrollment Among Patients with Hepatobiliary Cancers
Speaker: Chiang, Jennifer, MD, MS - Stanford Health Care, Stanford, CA
3:00 PM - 4:00 PM ET

2036 - Safety and Local Control of 5-Aminolevulinic Acid Fluorescence-Guided Surgery Combined with Cesium-131 Brachytherapy for Glioblastoma: A Matched-Pair Analysis
Speaker: Chodakiewitz, Michael, MD - Tufts Medical Center | Beth Israel Deaconess Medical Center, Boston, MA
3:00 PM - 4:00 PM ET

2037 - Association Between Rectal Cancer Magnetic Resonance Extramural Venous Invasion (mrEMVI) and Metachronous Liver and Lung Metastases
Speaker: Choi, Michelle, BS - University of Alberta, Edmonton, AB
3:00 PM - 4:00 PM ET

2038 - Early Experience and Impact of Curative-Intent Treatment on Esophageal Cancer Outcomes in a Newly Established Tertiary Cancer Centre in North India
Speaker: Choubey, Ajay, MBBS, DNB - Homi Bhabha Cancer Hospital and Research Centre, varanasi, Uttar Prad
3:00 PM - 4:00 PM ET

2039 - Association of Serum Metabolomic Signatures with Survival in Pancreatic Cancer Patients Undergoing Neoadjuvant Therapy
Speaker: Choudhary, Diya, BS - University of Texas MD Anderson Cancer Center, Houston, TX
10:55 AM - 11:05 AM ET

204 - Tislelizumab plus P-GemOx-14 and Radiotherapy for Early-Stage High-Risk Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Phase 2 Trial
Speaker: Qi, Shunan, MD - Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing
3:00 PM - 4:00 PM ET

2040 - Radiosurgery Outcomes for Patients with Significant Intra-Cranial Disease Burden with =50 Brain Metastases
Speaker: Chung, Anna, BS - University of Texas Southwestern Medical Center, Dallas, TX
3:00 PM - 4:00 PM ET

2041 - Risk Factors for Treatment-Related Effects in Brainstem Metastases Following Stereotactic Radiosurgery
Speaker: Colson-Fearon, Darien, MD, MPH - MD Anderson Cancer Center, Houston, TX
3:00 PM - 4:00 PM ET

2042 - DECT Derived Quantitative Parameters and Clinical Features Predict Overall Survival of LA-ESCC Patients after nCRT
Speaker: Cui, Yongbin, PhD - Shandong Cancer Hospital and Institute, Jinan, Shandong
3:00 PM - 4:00 PM ET

2043 - Phase I Study of Radiation Dose Intensification with Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
Speaker: D'Souza, Alden, MD, MPHS - Washington University School of Medicine, Saint Louis, MO